Cause-specific mortality in patients with alcohol-related liver disease in Denmark: a population-based study
- PMID: 37660703
- DOI: 10.1016/S2468-1253(23)00192-9
Cause-specific mortality in patients with alcohol-related liver disease in Denmark: a population-based study
Abstract
Background: Increased knowledge of the causes of death will be essential to prevent premature death in alcohol-related liver disease. We examined cause-specific mortality, including death due to specific cancers, in the 15 years after diagnosis of alcohol-related liver disease.
Methods: We used nationwide health registries to identify patients (aged ≥18 years) with a first diagnosis of alcohol-related liver disease between Jan 1, 2002, and Dec 31, 2017, in Denmark and followed up patients for their underlying cause of death up to Dec 31, 2019. We estimated the cause-specific mortality and investigated whether the cause-specific mortality differed by sex, age (<50, 50-59, and ≥60 years), alcohol-related liver disease severity at diagnosis (decompensated cirrhosis, compensated cirrhosis, alcoholic hepatitis, and steatosis or unspecified liver disease), and presence of diabetes.
Findings: The study included 23 385 patients with incident alcohol-related liver disease. Patients had a median age of 58 years (IQR 51-65), 15 819 (68%) were men and 7566 (32%) were women, and 15 358 (66%) had cirrhosis. During 111 532 person-years of follow-up, 15 692 (67%) patients died. Liver disease was the leading cause of death. In the first 5 years after alcohol-related liver disease diagnosis, liver disease caused almost half of all deaths, and the 5-year risk of death due to liver disease was 25·8% (95% CI 25·3-26·4). Beyond 5 years, causes other than liver disease combined became more common; of these extrahepatic causes, cancer, cardiovascular disease, and alcohol use disorder were the most common. Hepatocellular carcinoma was the dominant cause of cancer death (10-year risk of 2·5%, 95% CI 2·3-2·7), followed by lung cancer (1·9%, 1·7-2·1). The 10-year risk of death due to liver disease (around 30%) was similar for patients in all age groups and independent of sex and diabetes but was three times higher for those with decompensated cirrhosis (46·7%, 44·8-48·4) than steatosis or unspecified liver disease (16·2%, 15·3-17·2).
Interpretation: Patients diagnosed with alcohol-related liver disease were at high risk of dying from liver disease many years after diagnosis, irrespective of age and sex. Death due to specific cancers, including hepatocellular carcinoma, each contributed minimally to the total mortality in patients with alcohol-related liver disease.
Funding: TrygFonden and the Novo Nordisk Foundation.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests We declare no competing interests.
Similar articles
-
Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis.J Hepatol. 2020 Nov;73(5):1030-1036. doi: 10.1016/j.jhep.2020.05.043. Epub 2020 Jun 5. J Hepatol. 2020. PMID: 32512015
-
Cause-specific mortality among patients with cirrhosis in a population-based cohort study in Ontario (2000-2017).Hepatol Commun. 2023 Jun 28;7(7):e00194. doi: 10.1097/HC9.0000000000000194. eCollection 2023 Jul 1. Hepatol Commun. 2023. PMID: 37378630 Free PMC article.
-
Causes of death in people with liver cirrhosis in England compared with the general population: a population-based cohort study.Am J Gastroenterol. 2015 Aug;110(8):1149-58. doi: 10.1038/ajg.2015.191. Epub 2015 Jul 14. Am J Gastroenterol. 2015. PMID: 26169512
-
Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): an attempted network meta-analysis.Cochrane Database Syst Rev. 2017 Mar 31;3(3):CD011646. doi: 10.1002/14651858.CD011646.pub2. Cochrane Database Syst Rev. 2017. PMID: 28368093 Free PMC article. Review.
-
Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.Dan Med J. 2018 Apr;65(4):B5454. Dan Med J. 2018. PMID: 29619932 Review.
Cited by
-
Impact of low alcohol consumption in the natural history of cirrhosis.Hepatobiliary Surg Nutr. 2024 Feb 1;13(1):161-164. doi: 10.21037/hbsn-23-615. Epub 2024 Jan 16. Hepatobiliary Surg Nutr. 2024. PMID: 38322204 Free PMC article. No abstract available.
-
ALT levels, alcohol use, and metabolic risk factors have prognostic relevance for liver-related outcomes in the general population.JHEP Rep. 2024 Jul 24;6(10):101172. doi: 10.1016/j.jhepr.2024.101172. eCollection 2024 Oct. JHEP Rep. 2024. PMID: 39430577 Free PMC article.
-
Adverse health outcomes in offspring of parents with alcohol-related liver disease: Nationwide Danish cohort study.PLoS Med. 2024 Oct 23;21(10):e1004483. doi: 10.1371/journal.pmed.1004483. eCollection 2024 Oct. PLoS Med. 2024. PMID: 39441845 Free PMC article.
-
Alcohol-associated liver disease.J Clin Invest. 2024 Feb 1;134(3):e176345. doi: 10.1172/JCI176345. J Clin Invest. 2024. PMID: 38299591 Free PMC article. Review.
-
Transforming steatotic liver disease management: The emerging role of GLP-1 receptor agonists.Hepatol Commun. 2024 Oct 10;8(11):e0561. doi: 10.1097/HC9.0000000000000561. eCollection 2024 Nov 1. Hepatol Commun. 2024. PMID: 39392766 Free PMC article. Review.
LinkOut - more resources
Full Text Sources
Research Materials